Physician profile
Arlene Pak
NPI 1174866206
$6,902.85
in general payments reported to CMS, 2019-2025
45 companies · $2,117 in 2025
The $2,117 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $368 · 2021: $651 · 2022: $855 · 2023: $1,254 · 2024: $1,044 · 2025: $2,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,261 · Travel and Lodging: $1,064 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,260.71 |
| Travel and Lodging | $1,064.34 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,298.97 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $651.44 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $541.24 | 2022-2025 | |
| Astellas Pharma US INC | $492.04 | 2022-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $482.44 | 2019-2025 | |
| Abbvie INC. | $388.96 | 2019-2025 | |
| Evofem Biosciences, INC. | $341.36 | 2020-2025 | Phexxi, Solosec, Phexx |
| Biogen, INC. | $248.44 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $245.16 | 2019-2022 | |
| Daiichi Sankyo INC. | $187.15 | 2019-2021 | |
| Organon LLC | $152.90 | 2022-2025 | Nexplanon |
| Astellas Pharma Global Development | $139.54 | 2023-2025 | Veozah |
| Agile Therapeutics, INC. | $135.90 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $132.46 | 2021-2025 | Slynd |
| Avion Pharmaceuticals | $130.30 | 2019-2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $125.24 | 2023-2024 | Accrufer |
| Sage Therapeutics, LLC | $91.59 | 2021-2023 | |
| Myriad Women'S Health, INC. | $90.12 | 2023 | |
| Channel Medsystems, INC. | $89.50 | 2023 | |
| Aspira Women'S Health INC | $89.34 | 2021-2024 | Ova1 |
| Amgen INC. | $85.78 | 2019-2024 | Evenity, Prolia |
| Biohaven Pharmaceutical Holding Company LTD. | $80.50 | 2022 | |
| Baxter Healthcare | $53.77 | 2021-2022 | |
| Ethicon US, LLC | $52.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $50.54 | 2019-2020 | |
| Coopersurgical, INC. | $49.34 | 2019-2025 | Endosee |
| Hologic Sales and Service, LLC | $45.68 | 2019-2024 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Myovant Sciences INC. | $38.31 | 2022 | |
| Novo Nordisk INC | $37.29 | 2024-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $35.66 | 2023-2024 | Gemtesa, Myfembree |
| Medicem INC. | $31.52 | 2020 | |
| Exact Sciences Corporation | $29.48 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lupin INC. | $28.42 | 2020-2021 | |
| Meditrina | $26.19 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $24.34 | 2020 | |
| Scynexis, INC. | $23.58 | 2022 | |
| Dexcom, INC. | $23.53 | 2025 | Dexcom G6 Transmitter |
| Millicent US INC | $22.11 | 2021 | |
| Medtronic, INC. | $18.78 | 2022 | |
| Mylan Pharmaceuticals INC. | $16.50 | 2021 | |
| Lsi Solutions INC | $16.05 | 2024 | Fornisee |
| Vertical Pharmaceuticals, LLC | $15.99 | 2019 | |
| Duchesnay USA Incorporated | $14.84 | 2019 | |
| Glaxosmithkline, LLC. | $14.82 | 2020 | |
| Gynesonics, INC. | $12.77 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.